T. Appelboom and A. Van-eigem, How ancient is temporal arteritis?, J Rheumatol, vol.17, issue.7, pp.929-960, 1990.

G. Hunder, The Early History of Giant Cell Arteritis and Polymyalgia Rheumatica: First Descriptions to 1970, Mayo Clinic Proceedings, vol.81, issue.8, pp.1071-1083, 2006.
DOI : 10.4065/81.8.1071

J. Barrier, P. Pion, R. Massari, P. Peltier, J. Rojouan et al., Epidemiologic approach to Horton's disease in the department of Loire-Atlantique. 110 cases in 10 years (1970-1979)]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, mars, vol.3, issue.1, pp.13-20, 1982.

C. Ramstead and A. Patel, Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, Can J Ophthalmol J Can Ophtalmol. avr, vol.42, issue.2, pp.295-298, 1998.

C. Smith, W. Fidler, and R. Pinals, The epidemiology of giant cell arteritis. Report of a Ten-Year Study in Shelby County, Tennessee, Arthritis & Rheumatism, vol.20, issue.10, pp.1214-1219, 1983.
DOI : 10.1002/art.1780261007

F. Jonasson, J. Cullen, and R. Elton, Temporal Arteritis, Scottish Medical Journal, vol.185, issue.2, pp.111-117, 1979.
DOI : 10.1177/003693307902400203

M. Sonnenblick, G. Nesher, Y. Friedlander, and A. Rubinow, GIANT CELL ARTERITIS IN JERUSALEM: A 12-YEAR EPIDEMIOLOGICAL STUDY, Rheumatology, vol.33, issue.10, pp.938-941, 1994.
DOI : 10.1093/rheumatology/33.10.938

S. Kobayashi, T. Yano, Y. Matsumoto, F. Numano, N. Nakajima et al., Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: The first government-supported nationwide survey, Arthritis & Rheumatism, vol.39, issue.4, pp.594-602, 2003.
DOI : 10.1002/art.11195

G. Haugeberg, P. Paulsen, and R. Bie, Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings, J Rheumatol. nov, vol.27, issue.11, pp.2624-2627, 2000.

P. Elling, A. Olsson, and H. Elling, Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection, J Rheumatol. janv, vol.23, issue.1, pp.112-119, 1996.

P. Boesen and S. Sørensen, Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a danish county, Arthritis & Rheumatism, vol.103, issue.3, pp.294-299, 1987.
DOI : 10.1002/art.1780300308

P. Franzén, S. Sutinen, and J. Von-knorring, Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988, J Rheumatol. févr, vol.19, issue.2, pp.273-276, 1992.

O. Baldursson, K. Steinsson, J. Björnsson, and J. Lie, Giant cell arteritis in Iceland., Arthritis & Rheumatism, vol.34, issue.7, pp.1007-1012, 1994.
DOI : 10.1002/art.1780370705

B. Zöller, X. Li, J. Sundquist, and K. Sundquist, Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden, Scandinavian Journal of Rheumatology, vol.11, issue.5, pp.487-497, 2013.
DOI : 10.1186/1471-2377-12-41

C. Salvarani, C. Crowson, O. Fallon, W. Hunder, G. Gabriel et al., Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period, Arthritis Care & Research, vol.29, issue.2, pp.264-268, 2004.
DOI : 10.1002/art.20227

C. Salvarani, P. Macchioni, F. Zizzi, W. Mantovani, F. Rossi et al., Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy, Arthritis & Rheumatism, vol.28, issue.3, pp.351-356, 1991.
DOI : 10.1002/art.1780340313

M. Gonzalez-gay, J. Miranda-filloy, M. Lopez-diaz, R. Perez-alvarez, C. Gonzalez-juanatey et al., Giant Cell Arteritis in Northwestern Spain, Medicine, vol.86, issue.2, pp.61-68, 2007.
DOI : 10.1097/md.0b013e31803d1764

Q. Zeng, S. Huang, and C. R. , 10-year epidemiological study on rheumatic diseases in Shantou area], Zhonghua Nei Ke Za Zhi. mars, vol.36, issue.3, pp.193-197, 1997.

R. Wigley, N. Zhang, Q. Zeng, C. Shi, D. Hu et al., Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations, J Rheumatol. août, vol.21, issue.8, pp.1484-1490, 1994.

B. Richards, L. March, and S. Gabriel, Epidemiology of large-vessel vasculidities, Best Practice & Research Clinical Rheumatology, vol.24, issue.6, pp.871-883, 2010.
DOI : 10.1016/j.berh.2010.10.008

J. Cullen, B. Chan, C. Wong, and W. Chew, Giant cell (temporal) arteritis in Singapore: an occult case and the rationale of treatment, Singapore Med J. janv, vol.51, issue.1, pp.73-77, 2010.

I. Chaudhry, F. Shamsi, E. Elzaridi, Y. Arat, T. Bosley et al., Epidemiology of giant-cell arteritis in an Arab population: a 22-year study, British Journal of Ophthalmology, vol.91, issue.6, pp.715-718, 2007.
DOI : 10.1136/bjo.2006.108845

L. Pereira, M. Yoon, T. Hwang, J. Hong, K. Ray et al., Giant cell arteritis in Asians: a comparative study, British Journal of Ophthalmology, vol.95, issue.2, pp.214-216, 2011.
DOI : 10.1136/bjo.2009.177220

N. Liu, L. Labree, S. Feldon, and N. Rao, The epidemiology of giant cell arteritis, Ophthalmology, vol.108, issue.6, pp.1145-1149, 2001.
DOI : 10.1016/S0161-6420(01)00574-7

V. Devauchelle-pensec, S. Jousse, C. Destombe, and A. Saraux, Epid??miologie, imagerie et traitement de la maladie de Horton, Revue du Rhumatisme, vol.75, issue.5, pp.392-397, 2008.
DOI : 10.1016/j.rhum.2007.09.008

M. Khalifa, M. Karmani, N. Jaafoura, N. Kaabia, A. Letaief et al., Epidemiological and clinical features of giant cell arteritis in Tunisia, European Journal of Internal Medicine, vol.20, issue.2, pp.208-212, 2009.
DOI : 10.1016/j.ejim.2008.07.030

M. Bas-lando, G. Breuer, Y. Berkun, M. Mates, M. Sonnenblick et al., The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations, Clin Exp Rheumatol. févr, vol.25, issue.1, pp.15-17, 2007.

K. Ly, E. Liozon, A. Fauchais, and E. Vidal, Physiopathologie de l???art??rite ?? cellules g??antes, La Revue de M??decine Interne, vol.34, issue.7
DOI : 10.1016/j.revmed.2013.02.037

J. Lee, S. Naguwa, G. Cheema, and M. Gershwin, The Geo-epidemiology of Temporal (Giant Cell) Arteritis, Clinical Reviews in Allergy & Immunology, vol.65, issue.1-2, pp.88-95, 2008.
DOI : 10.1007/s12016-008-8075-0

L. Guillevin and B. Terrier, Classification des vascularites syst??miques, La Presse M??dicale, vol.41, issue.10, pp.986-995, 2012.
DOI : 10.1016/j.lpm.2012.06.006

G. Hunder, D. Bloch, B. Michel, M. Stevens, W. Arend et al., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis & Rheumatism, vol.33, issue.8, pp.1122-1128, 1990.
DOI : 10.1002/art.1780330810

I. Marie, Maladie de Horton et pseudopolyarthrite rhizomélique : critères diagnostiques. Rev Médecine Interne [Internet]. [cité 21 juin 2013]; Disponible sur: http://www.sciencedirect.com/science
DOI : 10.1016/j.revmed.2013.02.025

L. Page, L. Duhaut, P. Seydoux, D. Bosshard, S. Ecochard et al., Incidence des??accidents cardiovasculaires au??cours de??la??maladie de??Horton??: r??sultats pr??liminaires de??l'??tude prospective en??double cohorte GRACG, La Revue de M??decine Interne, vol.27, issue.2, pp.98-105, 2006.
DOI : 10.1016/j.revmed.2005.10.009

C. Salvarani, F. Cantini, L. Boiardi, and G. Hunder, Polymyalgia Rheumatica and Giant-Cell Arteritis, New England Journal of Medicine, vol.347, issue.4, pp.261-271, 2002.
DOI : 10.1056/NEJMra011913

K. Calamia and G. Hunder, Giant Cell Arteritis (Temporal Arteritis) Presenting as Fever of Undetermined Origin, Arthritis & Rheumatism, vol.52, issue.11, pp.1414-1418, 1981.
DOI : 10.1002/art.1780241113

C. Salvarani and G. Hunder, Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis, Arthritis & Rheumatism, vol.94, issue.6, pp.1259-1266, 1999.
DOI : 10.1002/1529-0131(199906)42:6<1259::AID-ANR24>3.0.CO;2-I

M. González-gay, R. Blanco, V. Rodríguez-valverde, V. Martínez-taboada, M. Delgado-rodriguez et al., Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment, Arthritis & Rheumatism, vol.40, issue.8, pp.1497-1504, 1998.
DOI : 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z

R. Caselli, G. Hunder, and J. Whisnant, Neurologic disease in biopsy-proven giant cell (temporal) arteritis, Neurology, vol.38, issue.3, pp.352-359, 1988.
DOI : 10.1212/WNL.38.3.352

T. Larson, S. Hall, N. Hepper, and G. Hunder, Respiratory Tract Symptoms as a Clue to Giant Cell Arteritis, Annals of Internal Medicine, vol.101, issue.5, pp.594-597, 1984.
DOI : 10.7326/0003-4819-101-5-594

M. Boettinger, M. Boettinger, S. Sebastian, S. Sebastian, M. Gamulescu et al., Bilateral vertebral artery occlusion with retrograde basilary flow in three cases of giant cell arteritis, Case Reports, vol.2009, issue.feb24 1, 2009.
DOI : 10.1136/bcr.07.2008.0488

T. Kermani, J. Schmidt, C. Crowson, S. Ytterberg, G. Hunder et al., Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis, Seminars in Arthritis and Rheumatism, vol.41, issue.6, pp.866-871, 2012.
DOI : 10.1016/j.semarthrit.2011.10.005

P. Duhaut, M. Berruyer, L. Pinede, S. Demolombe-rague, R. Loire et al., Anticardiolipin antibodies and giant cell arteritis: A prospective, multicenter case-control study, Arthritis & Rheumatism, vol.332, issue.4, pp.701-709, 1998.
DOI : 10.1002/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P

E. Liozon, P. Roblot, D. Paire, V. Loustaud, F. Liozon et al., Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases, Rheumatology, vol.39, issue.10, pp.1089-1094, 2000.
DOI : 10.1093/rheumatology/39.10.1089

E. Liozon, V. Roussel, P. Roblot, F. Liozon, J. Preud-'homme et al., Absence of anti-beta2 glycoprotein I antibodies in giant cell arteritis: a study of 45 biopsy-proven cases, Rheumatology, vol.37, issue.10, pp.1129-1131, 1998.
DOI : 10.1093/rheumatology/37.10.1129

N. Baerlecken, A. Linnemann, W. Gross, F. Moosig, T. Vazquez-rodriguez et al., Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica, Annals of the Rheumatic Diseases, vol.71, issue.6, pp.943-947, 2012.
DOI : 10.1136/annrheumdis-2011-200413

A. Régent, K. Ly, A. Blet, C. Agard, X. Puéchal et al., Quelle place pour le dosage des anticorps anti-ferritine au cours de l'artérite à cellules géantes ? Rev Médecine Interne, déc, vol.33, issue.2, p.54, 2012.

W. Schmidt, H. Kraft, K. Vorpahl, L. Völker, and E. Gromnica-ihle, Color Duplex Ultrasonography in the Diagnosis of Temporal Arteritis, New England Journal of Medicine, vol.337, issue.19, pp.1336-1342, 1997.
DOI : 10.1056/NEJM199711063371902

F. Karassa, M. Matsagas, W. Schmidt, and J. Ioannidis, Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis, Annals of Internal Medicine, vol.142, issue.5, pp.359-369, 2005.
DOI : 10.7326/0003-4819-142-5-200503010-00011

M. Karahaliou, G. Vaiopoulos, S. Papaspyrou, M. Kanakis, K. Revenas et al., Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis, Arthritis Research & Therapy, vol.8, issue.4, p.116, 2006.
DOI : 10.1186/ar2003

L. Begarin, A. Dumesnil, C. Assie-chauvier, Y. Benhamou, N. Cailleux-talbot et al., Performance diagnostique de nouveaux crit??res ??chographiques dans la maladie de Horton??: mesure de l?????paississement temporal et rapport ?? l?????paisseur intima-media carotidienne, La Revue de M??decine Interne, vol.34, p.75, 2013.
DOI : 10.1016/j.revmed.2013.10.115

E. Brunetti, M. Choukroun, J. Constans, C. Conri, and D. Midy, ??valuation des performances de l?????chographie-doppler des art??res temporales pour le diagnostic de maladie de horton. ?? propos de 39 examens, Journal des Maladies Vasculaires, vol.31, issue.4, p.29, 2006.
DOI : 10.1016/S0398-0499(06)76598-2

T. Bley, M. Uhl, J. Carew, M. Markl, D. Schmidt et al., Diagnostic Value of High-Resolution MR Imaging in Giant Cell Arteritis, American Journal of Neuroradiology, vol.28, issue.9, pp.1722-1727, 2007.
DOI : 10.3174/ajnr.A0638

T. Bley, T. Ness, K. Warnatz, A. Frydrychowicz, M. Uhl et al., Influence of corticosteroid treatment on MRI findings in giant cell arteritis, Clinical Rheumatology, vol.65, issue.2, pp.1541-1543, 2007.
DOI : 10.1007/s10067-006-0427-7

D. Blockmans, A. Maes, S. Stroobants, J. Nuyts, G. Bormans et al., New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography, Rheumatology, vol.38, issue.5, pp.444-447, 1999.
DOI : 10.1093/rheumatology/38.5.444

F. Besson, J. Parienti, B. Bienvenu, J. Prior, S. Costo et al., Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.11, pp.1764-1772, 2011.
DOI : 10.1007/s00259-011-1830-0

G. Treglia, M. Mattoli, L. Leccisotti, G. Ferraccioli, and A. Giordano, Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review, Clinical Rheumatology, vol.50, issue.3 Suppl 49, pp.1265-1275, 2011.
DOI : 10.1007/s10067-011-1828-9

É. Liozon and J. Monteil, Place de la tomographie par ??mission de positons (TEP) au [18F]FDG dans l???exploration des vascularites, M??decine Nucl??aire, vol.32, issue.10, pp.511-522, 2008.
DOI : 10.1016/j.mednuc.2008.07.003

R. Niederkohr and L. Levin, A Bayesian Analysis of the True Sensitivity of a Temporal Artery Biopsy, Investigative Opthalmology & Visual Science, vol.48, issue.2, pp.675-680, 2007.
DOI : 10.1167/iovs.06-1106

H. Saedon, M. Saedon, S. Goodyear, T. Papettas, and C. Marshall, Temporal artery biopsy for giant cell arteritis: retrospective audit Disponible sur, JRSM Short Rep [Internet], vol.223, issue.10
DOI : 10.1258/shorts.2012.012069

URL : http://doi.org/10.1258/shorts.2012.012069

G. Breuer, R. Nesher, and G. Nesher, Effect of biopsy length on the rate of positive temporal artery biopsies, Clin Exp Rheumatol. févr, vol.27, issue.1, pp.10-13, 2009.

A. Mahr, M. Saba, M. Kambouchner, M. Polivka, M. Baudrimont et al., Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?, Annals of the Rheumatic Diseases, vol.65, issue.6, pp.826-828, 2006.
DOI : 10.1136/ard.2005.042770

E. Ypsilantis, E. Courtney, N. Chopra, A. Karthikesalingam, M. Eltayab et al., Importance of specimen length during temporal artery biopsy, British Journal of Surgery, vol.56, issue.Suppl 52, pp.1556-1560, 2011.
DOI : 10.1002/bjs.7595

L. Guillevin, A. Mahr, and P. Cohen, Les vascularites n??crosantes syst??miques??: classification et strat??gies actuelles de traitement, La Revue de M??decine Interne, vol.24, issue.3, pp.172-182, 2003.
DOI : 10.1016/S0248-8663(02)00815-9

M. Gonzalez-gay, C. Garcia-porrua, A. Hajeer, A. Dababneh, and W. Ollier, HLA-DRB1*04 may be a marker of severity in giant cell arteritis, Annals of the Rheumatic Diseases, vol.59, issue.7, pp.574-575, 2000.
DOI : 10.1136/ard.59.7.574a

A. Enjuanes, Y. Benavente, J. Hernández-rodríguez, C. Queralt, J. Yagüe et al., Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes, Rheumatology, vol.51, issue.5, pp.841-851, 2012.
DOI : 10.1093/rheumatology/ker429

P. Blanco, A. Palucka, V. Pascual, and J. Banchereau, Dendritic cells and cytokines in human inflammatory and autoimmune diseases, Cytokine & Growth Factor Reviews, vol.19, issue.1, pp.41-52, 2008.
DOI : 10.1016/j.cytogfr.2007.10.004

URL : https://hal.archives-ouvertes.fr/hal-00275657

O. Pryshchep, W. Ma-krupa, B. Younge, J. Goronzy, and C. Weyand, Vessel-Specific Toll-Like Receptor Profiles in Human Medium and Large Arteries, Circulation, vol.118, issue.12, pp.1276-1284, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.789172

J. Deng, W. Ma-krupa, A. Gewirtz, B. Younge, J. Goronzy et al., Toll-Like Receptors 4 and 5 Induce Distinct Types of Vasculitis, Circulation Research, vol.104, issue.4, pp.488-495, 2009.
DOI : 10.1161/CIRCRESAHA.108.185777

W. Ma-krupa, M. Jeon, S. Spoerl, T. Tedder, J. Goronzy et al., Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis, The Journal of Experimental Medicine, vol.42, issue.2, pp.173-183, 2004.
DOI : 10.1002/art.10071

W. Krupa, M. Dewan, M. Jeon, P. Kurtin, B. Younge et al., Trapping of Misdirected Dendritic Cells in the Granulomatous Lesions of Giant Cell Arteritis, The American Journal of Pathology, vol.161, issue.5
DOI : 10.1016/S0002-9440(10)64458-6

A. Brack, A. Geisler, V. Martinez-taboada, B. Younge, J. Goronzy et al., Giant cell vasculitis is a T cell-dependent disease, Mol Med Camb Mass. août, vol.3, issue.8, pp.530-543, 1997.

J. Deng, B. Younge, R. Olshen, J. Goronzy, and C. Weyand, Th17 and Th1 T-Cell Responses in Giant Cell Arteritis, Circulation, vol.121, issue.7, pp.906-915, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.872903

C. Weyand, M. Kaiser, H. Yang, B. Younge, and J. Goronzy, Therapeutic effects of acetylsalicylic acid in giant cell arteritis, Arthritis & Rheumatism, vol.134, issue.2, pp.457-66, 2002.
DOI : 10.1002/art.10071

M. Samson and B. Bonnotte, Pathog??nie de l???art??rite ?? cellules g??antes, La Presse M??dicale, vol.41, issue.10, pp.937-947, 2012.
DOI : 10.1016/j.lpm.2012.07.005

R. Schmits, B. Kubuschok, S. Schuster, K. Preuss, and M. Pfreundschuh, Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica, Clinical & Experimental Immunology, vol.380, issue.2, pp.379-85, 2002.
DOI : 10.1046/j.1365-2249.2002.01751.x

A. Régent, H. Dib, K. Ly, C. Agard, M. Tamby et al., Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach, Arthritis Research & Therapy, vol.13, issue.3, p.107, 2011.
DOI : 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2

C. Weyand, A. Wagner, J. Bjornsson, and J. Goronzy, Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis., Journal of Clinical Investigation, vol.98, issue.7, pp.1642-1649, 1996.
DOI : 10.1172/JCI118959

A. Rodríguez-pla, J. Bosch-gil, J. Rosselló-urgell, P. Huguet-redecilla, and J. Stone, Metalloproteinase-2 and -9 in Giant Cell Arteritis: Involvement in Vascular Remodeling, Circulation, vol.112, issue.2, pp.264-269, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.520114

H. Rittner, V. Hafner, P. Klimiuk, L. Szweda, J. Goronzy et al., Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis, Journal of Clinical Investigation, vol.103, issue.7, pp.1007-1013, 1999.
DOI : 10.1172/JCI4711

M. Kaiser, C. Weyand, J. Björnsson, and J. Goronzy, Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis, Arthritis & Rheumatism, vol.96, issue.4, pp.623-633, 1998.
DOI : 10.1002/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6

M. Kaiser, B. Younge, J. Björnsson, J. Goronzy, and C. Weyand, Formation of New Vasa Vasorum in Vasculitis, The American Journal of Pathology, vol.155, issue.3, pp.765-774, 1999.
DOI : 10.1016/S0002-9440(10)65175-9

M. Cid, M. Cebrián, C. Font, B. Coll-vinent, J. Hernández-rodríguez et al., Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: Inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions, Arthritis & Rheumatism, vol.333, issue.1, pp.184-194, 2000.
DOI : 10.1002/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N

M. Cid, J. Hernández-rodríguez, M. Esteban, M. Cebrián, Y. Gho et al., Tissue and Serum Angiogenic Activity Is Associated With Low Prevalence of Ischemic Complications in Patients With Giant-Cell Arteritis, Circulation, vol.106, issue.13, pp.1664-1671, 2002.
DOI : 10.1161/01.CIR.0000030185.67510.C0

J. Hernández-rodríguez, M. Segarra, C. Vilardell, M. Sánchez, A. García-martínez et al., Tissue production of pro-inflammatory cytokines (IL-1??, TNF?? and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis, Rheumatology, vol.43, issue.3, pp.294-301, 2004.
DOI : 10.1093/rheumatology/keh058

P. Duhaut, Maladie de Horton et pseudopolyarthrite rhizom??lique??: nouveaut??s th??rapeutiques??? ??volution et pronostic, La Revue de M??decine Interne, vol.29, pp.281-285, 2008.
DOI : 10.1016/j.revmed.2008.10.008

A. Uddhammar, A. Eriksson, L. Nyström, R. Stenling, and S. Rantapää-dahlqvist, Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden, J Rheumatol. avr, vol.29, issue.4, pp.737-742, 2002.

C. Bisgård, H. Sloth, N. Keiding, and K. Juel, Excess mortality in giant cell arteritis, Journal of Internal Medicine, vol.299, issue.Suppl. 658, pp.119-123, 1991.
DOI : 10.1111/j.1365-2796.1991.tb00418.x

R. Crow, B. Katz, J. Warner, S. Alder, K. Zhang et al., Giant Cell Arteritis and Mortality, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.64, issue.3, pp.365-369, 2009.
DOI : 10.1093/gerona/gln030

G. Nesher, M. Sonnenblick, and Y. Friedlander, Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients, J Rheumatol. juill, vol.21, issue.7, pp.1283-1286, 1994.

E. Nordborg and B. Bengtsson, Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy., BMJ, vol.299, issue.6698, pp.549-550, 1989.
DOI : 10.1136/bmj.299.6698.549

J. Gran, G. Myklebust, T. Wilsgaard, and B. Jacobsen, Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls, Rheumatology, vol.40, issue.11, pp.1238-1242, 2001.
DOI : 10.1093/rheumatology/40.11.1238

J. Schmidt, P. Duhaut, V. Salle, A. Smail, D. Chatelain et al., Causes de mortalit?? dans la maladie de Horton et la pseudopolyarthrite rhizom??lique??: ??tude prospective en double cohorte GRACG, La Revue de M??decine Interne, vol.29, pp.324-325, 2008.
DOI : 10.1016/j.revmed.2008.10.102

C. Mukhtyar, L. Guillevin, M. Cid, B. Dasgupta, K. Groot et al., EULAR recommendations for the management of large vessel vasculitis, Annals of the Rheumatic Diseases, vol.68, issue.3, pp.318-323, 2009.
DOI : 10.1136/ard.2008.088351

R. Tehrani, R. Ostrowski, R. Hariman, and W. Jay, Giant Cell Arteritis: Oral Versus Intravenous Corticosteroids, Neuro-Ophthalmology, vol.31, issue.6, pp.1-15, 2009.
DOI : 10.1080/01658100802716754

S. Hayreh and B. Zimmerman, Management of Giant Cell Arteritis, Ophthalmologica, vol.217, issue.4, pp.239-259, 2003.
DOI : 10.1159/000070631

M. Mazlumzadeh, G. Hunder, K. Easley, K. Calamia, E. Matteson et al., Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial, Arthritis & Rheumatism, vol.43, issue.10, pp.3310-3318, 2006.
DOI : 10.1002/art.22163

A. Mahr, J. Jover, R. Spiera, C. Hernández-garcía, B. Fernández-gutiérrez et al., Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis, Arthritis & Rheumatism, vol.37, issue.8, pp.2789-2797, 2007.
DOI : 10.1002/art.22754

H. De-boysson, J. Boutemy, C. Creveuil, Y. Ollivier, P. Letellier et al., Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review, Seminars in Arthritis and Rheumatism, vol.43, issue.1, pp.105-112, 2013.
DOI : 10.1016/j.semarthrit.2012.12.023

D. Silva, M. Hazleman, and B. , Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study., Annals of the Rheumatic Diseases, vol.45, issue.2, pp.136-138, 1986.
DOI : 10.1136/ard.45.2.136

G. Hoffman, M. Cid, K. Rendt-zagar, P. Merkel, C. Weyand et al., Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis, Annals of Internal Medicine, vol.146, issue.9, pp.621-630, 2007.
DOI : 10.7326/0003-4819-146-9-200705010-00004

C. Salvarani, P. Macchioni, C. Manzini, G. Paolazzi, A. Trotta et al., Infliximab plus Prednisone or Placebo plus Prednisone for the Initial Treatment of Polymyalgia Rheumatica, Annals of Internal Medicine, vol.146, issue.9, pp.631-639, 2007.
DOI : 10.7326/0003-4819-146-9-200705010-00005

G. Pazzola, I. Padovano, L. Boiardi, A. Versari, N. Pipitone et al., Tocilizumab in glucocorticoid-naïve large-vessel vasculitis, Clin Exp Rheumatol. févr, vol.31, issue.1, pp.59-61, 2013.

K. Ly, J. Stirnemann, E. Liozon, M. Michel, O. Fain et al., Interleukin-1 blockade in refractory giant cell arteritis, Joint Bone Spine, vol.81, issue.1, 2013.
DOI : 10.1016/j.jbspin.2013.06.004

M. Alba, A. García-martínez, S. Prieto-gonzález, G. Espígol-frigolé, M. Butjosa et al., Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis, Disponible sur, 2014.
DOI : 10.1016/j.semarthrit.2013.10.009

M. Lee, S. Smith, A. Galor, and G. Hoffman, Antiplatelet and anticoagulant therapy in patients with giant cell arteritis, Arthritis & Rheumatism, vol.41, issue.10, pp.3306-3309, 2006.
DOI : 10.1002/art.22141

C. Salvarani, D. Bella, C. Cimino, L. Macchioni, P. Formisano et al., Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis, Rheumatology, vol.48, issue.3, pp.250-253, 2009.
DOI : 10.1093/rheumatology/ken465

M. Gonzalez-gay, T. Vazquez-rodriguez, I. Gomez-acebo, R. Pego-reigosa, M. Lopez-diaz et al., Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis, Medicine, vol.88, issue.4, pp.227-235, 2009.
DOI : 10.1097/MD.0b013e3181af4518

G. Nesher, Y. Berkun, M. Mates, M. Baras, R. Nesher et al., Risk Factors for Cranial Ischemic Complications in Giant Cell Arteritis, Medicine, vol.83, issue.2, pp.114-122, 2004.
DOI : 10.1097/01.md.0000119761.27564.c9

URL : http://doi.org/10.1097/01.md.0000119761.27564.c9

T. Zenone and M. Puget, Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis, Rheumatology International, vol.42, issue.Suppl 36
DOI : 10.1007/s00296-013-2814-0

S. Mackie, B. Dasgupta, L. Hordon, A. Gough, M. Green et al., Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors, Rheumatology, vol.50, issue.11, pp.2014-2022, 2011.
DOI : 10.1093/rheumatology/ker265

R. Solans-laqué, J. Bosch-gil, C. Molina-catenario, A. Ortega-aznar, J. Alvarez-sabin et al., Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis, Medicine, vol.87, issue.6, pp.335-344, 2008.
DOI : 10.1097/MD.0b013e3181908e96

J. Säve-söderbergh, B. Malmvall, R. Andersson, and B. Bengtsson, Giant cell arteritis as a cause of death. Report of nine cases, JAMA: The Journal of the American Medical Association, vol.255, issue.4, pp.493-496, 1986.
DOI : 10.1001/jama.255.4.493

S. Rüegg, S. Engelter, C. Jeanneret, A. Hetzel, A. Probst et al., Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis, Medicine, vol.82, issue.1, pp.1-12, 2003.
DOI : 10.1097/00005792-200301000-00001

C. Salvarani, C. Giannini, D. Miller, and G. Hunder, Giant cell arteritis: Involvement of intracranial arteries, Arthritis & Rheumatism, vol.48, issue.6, pp.985-989, 2006.
DOI : 10.1002/art.22359

E. Broalet, Y. Zunon-kippre, K. M. Legars, and D. , Microanatomie de la traversée durale de l'artère vertébrale, Rev Int Sci Médicales, vol.8, issue.3, pp.39-43, 2006.

I. Wilkinson and R. Russell, Arteries of the Head and Neck in Giant Cell Arteritis, Archives of Neurology, vol.27, issue.5, pp.378-391, 1972.
DOI : 10.1001/archneur.1972.00490170010003

M. Sheehan, C. Keohane, and C. Twomey, Fatal vertebral giant cell arteritis., Journal of Clinical Pathology, vol.46, issue.12, pp.1129-1131, 1993.
DOI : 10.1136/jcp.46.12.1129

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC501727/pdf

Z. Butt, J. Cullen, and E. Mutlukan, Pattern of arterial involvement of the head, neck, and eyes in giant cell arteritis: three case reports., British Journal of Ophthalmology, vol.75, issue.6, pp.368-371, 1991.
DOI : 10.1136/bjo.75.6.368

C. Garcia-porrua, R. Pego-reigosa, F. Martinez-vazquez, V. Armesto, and M. Gonzalez-gay, Bilateral vertebral artery occlusion in giant cell arteritis, Clin Exp Rheumatol. avr, vol.24, issue.2, p.101, 2006.

N. Chausson, S. Olindo, A. Signaté, P. Cohen-ténoudji, M. Aveillan et al., Angioplastie carotidienne bilat??rale chez une patiente avec infarctus c??r??bral sur maladie de Horton, Revue Neurologique, vol.166, issue.3, pp.328-332, 2010.
DOI : 10.1016/j.neurol.2009.05.011

K. Pfadenhauer, J. Weinerth, and C. Hrdina, Vertebral arteries: A target for FDG-PET imaging in giant cell arteritis?, Nuklearmedizin, vol.50, issue.1, pp.28-32, 2011.
DOI : 10.3413/nukmed-0335-10-07

R. Cull, Internal carotid artery occlusion caused by giant cell arteritis., Journal of Neurology, Neurosurgery & Psychiatry, vol.42, issue.11, pp.1066-1067, 1979.
DOI : 10.1136/jnnp.42.11.1066

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC490404/pdf

G. Howard, S. Ho, K. Kim, and J. Wallach, Bilateral carotid artery occlusion resulting from giant cell arteritis, Annals of Neurology, vol.27, issue.2, pp.204-211, 1984.
DOI : 10.1002/ana.410150216

C. Mclean, M. Gonzales, and J. Dowling, Systemic giant cell arteritis and cerebellar infarction, Stroke, vol.24, issue.6, pp.899-902, 1993.
DOI : 10.1161/01.STR.24.6.899

C. Weyand, N. Tetzlaff, J. Björnsson, A. Brack, B. Younge et al., Disease patterns and tissue cytokine profiles in giant cell arteritis, Arthritis & Rheumatism, vol.81, issue.1, pp.19-26, 1997.
DOI : 10.1002/art.1780400105

J. Hernández-rodríguez, M. Segarra, C. Vilardell, M. Sánchez, A. García-martínez et al., Elevated Production of Interleukin-6 Is Associated With a Lower Incidence of Disease-Related Ischemic Events in Patients With Giant-Cell Arteritis Angiogenic Activity of Interleukin-6 as a Potential Protective Mechanism. Circulation, pp.2428-2434, 2003.

B. Rueda, M. Lopez-nevot, M. Lopez-diaz, C. Garcia-porrua, J. Martín et al., A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis, J Rheumatol. sept, vol.32, issue.9, pp.1737-1741, 2005.

R. Pego-reigosa, C. Garcia-porrua, A. Piñeiro, T. Dierssen, J. Llorca et al., Predictors of cerebrovascular accidents in giant cell arteritis in a defined population

G. Nesher, Y. Berkun, M. Mates, M. Baras, A. Rubinow et al., Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis, Arthritis & Rheumatism, vol.20, issue.4, pp.1332-1337, 2004.
DOI : 10.1002/art.20171

J. Tervaert, Translational Mini-Review Series on Immunology of Vascular Disease: Accelerated atherosclerosis in vasculitis, Clinical & Experimental Immunology, vol.34, issue.2, pp.377-385, 2009.
DOI : 10.1111/j.1365-2249.2009.03885.x

M. Cid, C. Font, J. Oristrell, A. Sierra, B. Coll-vinent et al., Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis, Arthritis & Rheumatism, vol.31, issue.1, pp.26-32, 1998.
DOI : 10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0

M. Gonzalez-gay, M. Lopez-diaz, S. Barros, C. Garcia-porrua, A. Sanchez-andrade et al., Giant Cell Arteritis, Medicine, vol.84, issue.5, pp.277-290, 2005.
DOI : 10.1097/01.md.0000180043.19285.54

H. Autorité and D. Santé, Accident vasculaire cérébral : prise en charge précoce (alerte, phase préhospitalière, phase hospitalière initiale, indications de la thrombolyse) [Internet]. [cité 23 déc 2013]. Disponible sur: http://www.hassante.fr/portail/jcms/c_830203/fr/accident-vasculaire-cerebral-prise-en-charge-precoce- alerte-phase-prehospitaliere-phase-hospitaliere-initiale-indications-de-la- thrombolyse?xtmc=&xtcr=5

R. Caselli, Giant cell (temporal) arteritis: A treatable cause of multi-infarct dementia, Neurology, vol.40, issue.5, pp.753-755, 1990.
DOI : 10.1212/WNL.40.5.753

M. Zeidler, T. Hughes, and A. Zeman, Confused by arteritis. The Lancet, janv, vol.355, issue.9201, pp.374-375, 2000.
DOI : 10.1016/s0140-6736(99)11011-0

K. Pfadenhauer, M. Esser, and K. Berger, Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica--an ultrasonographic case-control study, J Rheumatol. déc, vol.32, issue.12, pp.2356-2360, 2005.

J. García-garcía, Ó. Ayo-martín, L. Argandoña-palacios, and T. Segura, Vertebral Artery Halo Sign in Patients With Stroke: A Key Clue for the Prompt Diagnosis of Giant Cell Arteritis, Stroke, vol.42, issue.11
DOI : 10.1161/STROKEAHA.111.625152

M. Md, D. Md, M. Md, and A. Md, Involvement of the vertebral arteries in giant cell arteritis mimicking vertebral dissection, J Neurol. 1 août, vol.250, issue.8, pp.1006-1009, 2003.

S. Mikiashvili, I. Pronin, and L. Metelkina, Spiral computed tomographic angiography in the diagnosis of vertebral artery occlusive lesions], Vestn Rentgenol Radiol. oct, issue.5, pp.21-24, 2007.

S. Khan, P. Rich, A. Clifton, and H. Markus, Noninvasive Detection of Vertebral Artery Stenosis, Stroke, vol.40, issue.11, pp.3499-3503, 2009.
DOI : 10.1161/STROKEAHA.109.556035

J. Baqué, A. Azarine, B. Beyssen, J. Bonneville, F. Cattin et al., Quand, comment et pourquoi r??aliser une imagerie des carotides extracr??niennes ?, Journal de Radiologie, vol.85, issue.6, pp.825-844, 2004.
DOI : 10.1016/S0221-0363(04)97689-5

A. Stanson, R. Klein, and G. Hunder, Extracranial angiographic findings in giant cell (temporal) arteritis, American Journal of Roentgenology, vol.127, issue.6, pp.957-963, 1976.
DOI : 10.2214/ajr.127.6.957

M. Markl, M. Uhl, O. Wieben, T. Ness, M. Langer et al., High resolution 3T MRI for the assessment of cervical and superficial cranial arteries in giant cell arteritis, Journal of Magnetic Resonance Imaging, vol.18, issue.2
DOI : 10.1002/jmri.20639

K. Khalaf, M. Pages, J. Blard, and P. Labauge, Two ischemic cerebral accidents in treated Horton disease: caused by adrenal cortex hormone therapy?]. Presse Médicale Paris Fr 1983. 5 mars, p.449, 1994.

H. Staunton, F. Stafford, M. Leader, and D. O-'riordain, Deterioration of Giant Cell Arteritis With Corticosteroid Therapy, Archives of Neurology, vol.57, issue.4, pp.581-584, 2000.
DOI : 10.1001/archneur.57.4.581

J. Collazos, C. García-moncó, A. Martín, J. Rodriguez, and M. Gómez, Multiple strokes after initiation of steroid therapy in giant cell arteritis., Postgraduate Medical Journal, vol.70, issue.821, pp.228-230, 1994.
DOI : 10.1136/pgmj.70.821.228

N. Dementovych, R. Mishra, and Q. Shah, Angioplasty and stent placement for complete occlusion of the vertebral artery secondary to giant cell arteritis, Journal of NeuroInterventional Surgery, vol.4, issue.2, pp.110-113, 2012.
DOI : 10.1136/jnis.2011.004689

A. Fitzgerald, J. Ironside, D. Summers, M. Dennis, and E. Mcrorie, Two Cases of Recurrent Stroke in Treated Giant Cell Arteritis, JCR: Journal of Clinical Rheumatology, vol.16, issue.5, pp.225-228, 2010.
DOI : 10.1097/RHU.0b013e3181e9a338

A. Kumar and D. Costa, Insidious posterior circulation stroke with rapid deterioration due to vertebral giant cell arteritis, Age and Ageing, vol.36, issue.6, pp.695-697, 2007.
DOI : 10.1093/ageing/afm136

URL : http://ageing.oxfordjournals.org/cgi/content/short/36/6/695

K. Polomat, N. Chausson, S. Olindo, and D. Smadja, R??gression de st??noses intracr??niennes vert??brobasilaires symptomatiques sous corticoth??rapie au cours d???une maladie de Horton, Revue Neurologique, vol.166, issue.11, pp.940-943, 2010.
DOI : 10.1016/j.neurol.2010.03.007

T. Haisa, T. Tsuda, K. Hagiwara, T. Kikuchi, and K. Seki, Vertebrobasilar Infarction Related to Giant Cell (Temporal) Arteritis: Case Report, Neurologia medico-chirurgica, vol.55, issue.1, pp.27-2013
DOI : 10.2176/nmc.cr.2013-0038

T. Büttner, N. Heye, and H. Przuntek, Temporal Arteritis with Cerebral Complications: Report of Four Cases, European Neurology, vol.34, issue.3, pp.162-167, 1994.
DOI : 10.1159/000117031

D. Conn, R. Tompkins, and W. Nichols, Glucocorticoids in the management of vasculitis--a double edged sword?, J Rheumatol. août, vol.15, issue.8, pp.1181-1183, 1988.

M. Paccalin, Z. Amoura, P. Roblot, P. Godeau, B. Becq-giraudon et al., Accidents vasculaires enc??phaliques pr??coces apr??s instauration d'une corticoth??rapie au cours de la maladie de Horton, La Revue de M??decine Interne, vol.21, issue.6, pp.550-554, 2000.
DOI : 10.1016/S0248-8663(00)89232-2

C. Masson, Therapeutic approach to giant cell arteritis, Joint Bone Spine, vol.79, issue.3, pp.219-227, 2012.
DOI : 10.1016/j.jbspin.2011.09.015

R. Ahdab, F. Thabuy, E. Menager-de-froberville, D. Virgillio, G. Brugieres et al., G - 2 St??nose vert??bro-basilaire r??versible sous cortico??des et anticoagulant au cours d???une maladie de Horton, Revue Neurologique, vol.163, issue.4, p.11, 2007.
DOI : 10.1016/S0035-3787(07)90508-1

S. Weisman and D. Graham, Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events, Archives of Internal Medicine, vol.162, issue.19, pp.2197-2202, 2002.
DOI : 10.1001/archinte.162.19.2197

G. Defuentes, F. Dutasta, and C. Ficko, Corticotherapie generale, Rev Prat Med Gen, issue.830, pp.741-786, 2009.

P. Berlit, Review: Diagnosis and treatment of cerebral vasculitis, Therapeutic Advances in Neurological Disorders, vol.322, issue.1, pp.29-42, 2010.
DOI : 10.1177/1756285609347123

C. Lu-emerson, M. Walker, B. Huber, B. Ghodke, J. Longstreth et al., Lethal giant cell arteritis with multiple ischemic strokes despite aggressive immunosuppressive therapy, Journal of the Neurological Sciences, vol.295, issue.1-2, pp.120-124, 2010.
DOI : 10.1016/j.jns.2010.05.008

C. Moroianu, M. Bentz, E. Revenco, C. Clerc, P. Richard et al., Maladie de Horton d?????volution fatale avec atteinte s??v??re bilat??rale des art??res vert??brales, Revue Neurologique, vol.162, issue.8-9, pp.8-9876, 2006.
DOI : 10.1016/S0035-3787(06)75095-0

K. Uchino, J. Pary, J. Grotta, K. Uchino, J. Pary et al., Accident vasculaire c??r??bral isch??mique
DOI : 10.1016/B978-2-8101-0122-1.00003-0

R. Durant, H. Blain, and C. Jeandel, Syndrome inflammatoire chez la personne ??g??e, EMC - M??decine, vol.2, issue.3, pp.284-290, 2005.
DOI : 10.1016/j.emcmed.2004.12.003

P. Duhaut, L. Pinede, H. Bornet, S. Demolombe-rague, C. Dumontet et al., Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease, Annals of the Rheumatic Diseases, vol.58, issue.6, pp.335-341, 1999.
DOI : 10.1136/ard.58.6.335

M. Gonzalez-gay, C. Garcia-porrua, J. Llorca, C. Gonzalez-louzao, and P. Rodriguez-ledo, Biopsy-negative giant cell arteritis: Clinical spectrum and predictive factors for positive temporal artery biopsy, Seminars in Arthritis and Rheumatism, vol.30, issue.4, pp.249-256, 2001.
DOI : 10.1053/sarh.2001.16650

S. Richard, R. Anxionnat, C. Delaunay, and X. Ducrocq, Giant Cell Arteritis Revealed by Vertebrobasilar Insufficiency, The Journal of Rheumatology, vol.36, issue.2, pp.457-458, 2009.
DOI : 10.3899/jrheum.080922

A. Néel, C. Pagnoux, L. Guillevin, and M. Hamidou, Les vascularites du syst??me nerveux central??: mise au point, La Revue de M??decine Interne, vol.33, issue.7, pp.381-389, 2012.
DOI : 10.1016/j.revmed.2011.11.020

L. Quartuccio, M. Maset, G. Maglio, E. Pontarini, M. Fabris et al., Role of oral cyclophosphamide in the treatment of giant cell arteritis, Rheumatology, vol.51, issue.9
DOI : 10.1093/rheumatology/kes127

L. Sailler, G. Pugnet, and B. Bienvenu, Traitement de la maladie de Horton, La Revue de M??decine Interne, vol.34, issue.7, pp.431-437, 2013.
DOI : 10.1016/j.revmed.2013.02.032

L. Fardet, Complications de la corticoth??rapie chez les patients souffrant de maladie de Horton ou de pseudopolyarthrite rhizom??lique, La Revue de M??decine Interne, vol.34, issue.7, pp.438-443, 2013.
DOI : 10.1016/j.revmed.2013.02.031

J. Hoes, J. Jacobs, M. Boers, D. Boumpas, F. Buttgereit et al., EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases, Annals of the Rheumatic Diseases, vol.66, issue.12, pp.1560-1567, 2007.
DOI : 10.1136/ard.2007.072157

. Disponible-sur, has-sante.fr/portail/jcms/c_437005/fr/prise-en-charge-de-l- osteoporose-la-has-publie-une-synthese-a-destination-des-professionnels-de- sante?xtmc=&xtcr=1